الفهرس | Only 14 pages are availabe for public view |
Abstract Background: Breast cancer is the most common cancer and the second leading cause of cancer mortality in women. Accurate diagnosis and staging are essential for the selection of the most appropriate therapeutic strategy and major determinants of patient prognosis and survival. Aim of the Work: The purpose of our study is to evaluate the potential role of 18F-FDG PET/CT in monitoring treatment of breast cancer and assessment of recurrence after surgical or systemic treatment. Patients and Methods This study is retrospective study , was conducted on (25) female patients over a period of 6 months. Their ages ranged from 34 to78 years with mean age of 52 years ,All patients have positive history of breast cancer treatment. Those patients were referred to the Radio diagnosis & nuclear medicine departments in Ain –shams university and private center . Results: FDG-PET-CT is the investigation of choice for post-treatment follow up of breast cancer. It has a greatest role in detection of newly developed lesions and for its greatest impact on detection of the disease progression. Conclusion: FDG-PET-CT is highly useful for monitoring response to therapeutic interventions. This technique can identify response to therapy earlier than any other imaging method currently available which greatly improves patient management by allowing termination of ineffective and toxic therapies. PET-CT proved to be helpful in the evaluation of anatomic regions that have been previously treated by surgery or radiation in which the discrimination between post-treatment scar and recurrent tumor can be problematic. |